Risk Prediction of Difficult Tracheal Intubation in OSAHS Patient

NCT ID: NCT04506346

Last Updated: 2020-08-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-09-30

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates the risk factors for difficult tracheal intubation in in obstructive sleep apnea hypopnea syndrome(OSAHS) patients undergoing uvulo-palato-pharyngoplast(UPPP)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

OSAHS patients are high risk group of difficult tracheal intubation. In clinical application, unexpected difficult tracheal intubation is not rare. Difficult airway is a significant problem to these patients and the physicans in terms of mortality and morbidity.

This study collects risk factors as physical examinations(including modified Mallampati grade, neck circumference, lateral clinical craniofacial assessment and body mass index ,BMI), Stopbang scores, polysommographic parameters (including apnea-hypopnea index, AHI and lowest SpO2, LSpO2), and special radiographic parameters in head and neck region. By using statistics method, predictive model to manage risks would be established.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Difficult Intubation Airway Obstruction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

OSAHS

patients with OSAHS, undergoing UPPP

difficult tracheal intubation

Intervention Type DIAGNOSTIC_TEST

Grade Ⅲ or Ⅳ according to Cormach-Lehane Grading of laryngoscopic view

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

difficult tracheal intubation

Grade Ⅲ or Ⅳ according to Cormach-Lehane Grading of laryngoscopic view

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* diagnosed as OSAHS.
* receive UPPP under general anesthesia in Beijing Tsinghua Changgung Hospital
* ASA grade I or II

Exclusion Criteria

* ASA grade III or above
* had received UPPP
* had fore-teeth loosed
* obstructive sleep apnea hypopnea were caused by hypothyroidism, acromegaly, or vocal cord paralysis.
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Beijing Tsinghua Chang Gung Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Huan Zhang, MD

Role: STUDY_CHAIR

department of anesthesia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

YAN SIYI

Beijing, Beijing Municipality, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

XMLX201824

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.